Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery
In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.
| Condition(s) | Lignocaine, Bupivacaine, Postpartum Perineal Pain, Vaginal Delivery, Episiotomy, Primigravidae |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae. |
| Who can participate | Inclusion Criteria: * Primigravidae with the full term undergoing vaginal delivery with episiotomy. * Pregnancies and singleton vertex cephalic fetuses. * In the active phase of the first stage of labor. Exclusion Criteria: * Patients with history of drug allergies to study drugs as this will increase the risk of complications. * Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs. * Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications. * Inability to cooperate as this will affect our assessment. * Patient's refusal. * Any intraoperative complications t |
| Ages | 18 Years to 40 Years |
| Sex | Female |
| Lead sponsor | Ain Shams University |
| Locations | Cairo, Egypt |
| Start date | 2024-03-01 |
| NCT ID | NCT06568289 |
| Official listing | https://clinicaltrials.gov/study/NCT06568289 |